What is the recommended timing and method for a gonorrhea test of cure after completing treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gonorrhea Test of Cure: Timing and Method

A test of cure for gonorrhea should be performed 1 week after treatment if alternative regimens are used (non-ceftriaxone treatments), with culture being the preferred method when available, or NAAT if culture is not available. 1

When to Perform Test of Cure

  • Routine test of cure is NOT recommended for patients who receive the standard recommended treatment (ceftriaxone 250 mg IM plus azithromycin 1 g orally) for uncomplicated urogenital or rectal gonorrhea 1, 2

  • Test of cure IS recommended in the following situations:

    • Patients treated with alternative regimens (cefixime 400 mg orally or azithromycin 2 g orally) should return for test of cure 1 week after treatment 1
    • Patients with pharyngeal gonorrhea (more difficult to eradicate than urogenital/rectal infections) 2
    • Patients with persistent symptoms after treatment 1, 2
    • Cases of suspected treatment failure 1

Preferred Testing Methods

  • Culture is the ideal method for test of cure as it:

    • Allows for antimicrobial susceptibility testing 1
    • Is essential in cases of suspected treatment failure 1
    • Should be performed at the infected anatomic site 1
  • If culture is not available, NAAT (Nucleic Acid Amplification Test) can be used:

    • Wait at least 7 days after treatment when using RNA-based NAATs 3, 4
    • Wait at least 14 days after treatment when using DNA-based NAATs 3, 5
    • Be aware that NAATs may detect residual DNA/RNA from dead organisms, potentially leading to false positives if performed too early 1, 3

Special Considerations

  • For suspected treatment failures:

    • Obtain specimen for culture and antimicrobial susceptibility testing 1
    • Report the case to local public health officials within 24 hours 1
    • Consult an infectious disease specialist 1
    • Consider alternative treatment regimens based on susceptibility results 1
  • Interpretation of positive test of cure results:

    • A positive NAAT result 2-3 weeks after treatment, in the absence of re-exposure, is indicative of treatment failure 1
    • Be aware of possible "blips" (isolated positive results after clearance) which occur in approximately 0.8-4.4% of cases depending on the NAAT type 3
    • Consider the possibility of reinfection from untreated partners 1, 2

Partner Management

  • All sex partners from the preceding 60 days should be evaluated and treated 1, 2
  • Patients should avoid sexual intercourse until therapy is completed and both they and their partners are asymptomatic 2
  • If partners' treatment cannot be ensured, consider expedited partner therapy 1, 2

Common Pitfalls to Avoid

  • Testing too early: Median time to clearance is approximately 2 days, but can range up to 7-15 days depending on the test type 3
  • Failing to obtain culture in treatment failure cases: Culture is essential for antimicrobial susceptibility testing 1
  • Not considering pharyngeal infections: These are more difficult to eradicate and may require test of cure even with standard treatment 2
  • Not addressing partner treatment: Untreated partners are a common source of reinfection 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Gonorrhea Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Test of Cure for Anogenital Gonorrhoea Using Modern RNA-Based and DNA-Based Nucleic Acid Amplification Tests: A Prospective Cohort Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.